iRhythm Technologies IRTC 深 沪
等待开盘 12-19 09:30:00 美东时间
168.48
+1.100
+0.66%
华盛通- 最 高173.25
- 今 开168.31
- 成交量 53.81万股
- 最 低 166.49
- 昨 收 167.38
- 总市值 54.28亿
- 52周最高 212.00
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 86.19
- 委 比 63.10%
- 总股本 3221.91万
- 历史最高 286.19
- 量 比 1.15
- 振 幅 4.04%
- 历史最低 22.25
- 每 手 1
- 风险率 31.63%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅101%！12家机构集体上调美光目标价；Insmed、RPM、Vital Farms等遭多家大行下调评级
今日重点评级关注：Ascendiant Capital：维持Society Pass"买入"评级，目标价从22美元升至22.5美元；HC Wainwright & Co.：维持Climb Bio"买入"评级，目标价从9美元升至11美元
今天 10:15
Truist Securities Maintains Buy on iRhythm Technologies, Lowers Price Target to $215
Truist Securities analyst Richard Newitter maintains iRhythm Technologies (NASDAQ:IRTC) with a Buy and lowers the price target from $230 to $215.
今天 00:14
Intuitive Surgical downgraded as Citi previews 2026 in MedTech
Issuing a largely positive outlook on the MedTech sector for 2026, Citi on Thursday upgraded Penumbra (PEN) and Bausch + Lomb (BLCO) on product launches but downgraded Intuitive Surgical (ISRG) and Ha...
12-12 03:05
美股大行评级 | 最高500美元！MongoDB获18家大行紧急上调目标价；巴克莱下调理想汽车目标价至18美元
今日重点评级关注：B. Riley证券：维持Seabridge Gold"买入"评级，目标价从50美元升至65美元；HC Wainwright & Co.：维持TRX Gold"买入"评级，目标价从1.2美元升至1.4美元
12-03 09:58
Morgan Stanley Maintains Overweight on iRhythm Technologies, Raises Price Target to $205
Morgan Stanley analyst Cecilia Furlong maintains iRhythm Technologies (NASDAQ:IRTC) with a Overweight and raises the price target from $195 to $205.
12-03 01:45
iRhythm Technologies Presents Large-Scale Data At APHRS/JHRS Showing Consistent Zio ECG Monitoring Performance Across Asian And Non-Asian Populations
iRhythm Technologies presented new data during the joint Asia Pacific Heart Rhythm Society (APHRS) and Japan Heart Rhythm Society (JHRS) scientific sessions.Large-scale analysis of more than 400,000 patients1 supports
11-21 21:14
iRhythm Technologies Highlights Revenue Growth and Expansion
Irhythm Technologies ( ($IRTC) ) just unveiled an update. On November 12, 2025,...
11-13 06:59
iRhythm Technologies Announces The Publication Of "Relationship Of Symptom Frequency And Symptom-Rhythm Correlation To Arrhythmia Type And Time To Detection: Insights From Ambulatory ECG Monitoring In Over 1 Million Patients," In The Journal Of The Heart Rhythm Society
Real-world data across more than 1 million patients published in Heart Rhythm show that 24–48-hour monitoring can miss actionable arrhythmias and highlights the value of iRhythm's Zio® long-term continuous
11-11 21:10
iRhythm Technologies to Participate in Upcoming Investor Conferences
iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare company, announced that its management team will present at four healthcare investor conferences in late 2025. The events include the Wolfe Research 2025 Healthcare Conference on November 18, 2025, the Jefferies 2025 Global Healthcare Conference on November 20, 2025, the Citi 2025 Global Healthcare Conference on December 3, 2025, and the Evercore 8th Annual Healthcare Confere...
11-04 21:30
Masimo Earnings Preview
Masimo (NASDAQ:MASI) will release its quarterly earnings report on Tuesday, 202...
11-04 00:02
